75 related articles for article (PubMed ID: 3485592)
1. Chelation therapy of incorporated plutonium-238 and americium-241: comparison of LICAM(C), DTPA and DFOA in rats, hamsters and mice.
Volf V
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Mar; 49(3):449-62. PubMed ID: 3485592
[TBL] [Abstract][Full Text] [Related]
2. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.
Miller SC; Liu G; Bruenger FW; Lloyd RD
Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916
[TBL] [Abstract][Full Text] [Related]
4. [Potency of peroral and parenteral administration of Zinc-DTPA for decorporation of 241Am from the gastrointestinal tract].
Ivannikov AT; Il'in LA; Zhorova ES; Popov BA; Parfenova IM
Radiats Biol Radioecol; 2004; 44(2):221-8. PubMed ID: 15174385
[TBL] [Abstract][Full Text] [Related]
5. Preferential decorporation of americium by pulmonary administration of DTPA dry powder after inhalation of aged PuO(2) containing americium in rats.
Grémy O; Tsapis N; Chau Q; Renault D; Abram MC; Van der Meeren A
Radiat Res; 2010 Nov; 174(5):637-44. PubMed ID: 20726717
[TBL] [Abstract][Full Text] [Related]
6. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL
Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098
[TBL] [Abstract][Full Text] [Related]
7. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation.
Grémy O; Tsapis N; Bruel S; Renault D; Van der Meeren A
Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632
[TBL] [Abstract][Full Text] [Related]
8. Decorporation Approach after Rat Lung Contamination with Plutonium: Evaluation of the Key Parameters Influencing the Efficacy of a Protracted Chelation Treatment.
Grémy O; Coudert S; Renault D; Miccoli L
Radiat Res; 2017 Nov; 188(5):552-561. PubMed ID: 28945525
[TBL] [Abstract][Full Text] [Related]
9. Targeting of diethylene triamine pentaacetic acid encapsulated in liposomes to rat liver: an effective strategy to prevent bone deposition and increase urine elimination of plutonium in rats.
Phan G; Ramounet-Le Gall B; Manceau J; Fanet M; Benech H; Fritsch P; Fattal E; Deverre JR
Int J Radiat Biol; 2004 Jun; 80(6):413-22. PubMed ID: 15362694
[TBL] [Abstract][Full Text] [Related]
10. DTPA-Coated Liposomes as a New Delivery Vehicle for Plutonium Decorporation.
Grémy O; Mougin-Degraef M; Devilliers K; Berdal M; Laroche P; Miccoli L
Radiat Res; 2021 Jan; 195(1):77-92. PubMed ID: 33180911
[TBL] [Abstract][Full Text] [Related]
11. Competitive binding of Pu and Am with bone mineral and novel chelating agents.
Guilmette RA; Hakimi R; Durbin PW; Xu J; Raymond KN
Radiat Prot Dosimetry; 2003; 105(1-4):527-34. PubMed ID: 14527022
[TBL] [Abstract][Full Text] [Related]
12. Decorporation of systemically distributed americium by a novel orally administered diethylenetriaminepentaacetic acid (DTPA) formulation in beagle dogs.
Wilson JP; Cobb RR; Dungan NW; Matthews LL; Eppler B; Aiello KV; Curtis S; Boger T; Guilmette RA; Weber W; Doyle-Eisele M; Talton JD
Health Phys; 2015 Mar; 108(3):308-18. PubMed ID: 25627942
[TBL] [Abstract][Full Text] [Related]
13. Comparative decorporation efficacy of 3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA after contamination of rats with soluble forms of 238Pu and 233U.
Ramounet-Le Gall B; Grillon G; Rateau G; Burgada R; Bailly T; Fritsch P
Radiat Prot Dosimetry; 2003; 105(1-4):535-8. PubMed ID: 14527023
[TBL] [Abstract][Full Text] [Related]
14. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
Taylor DM; Hodgson SA; Stradling N
Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
[TBL] [Abstract][Full Text] [Related]
15. Enhanced decorporation of plutonium by DTPA encapsulated in small PEG-coated liposomes.
Phan G; Le Gall B; Grillon G; Rouit E; Fouillit M; Benech H; Fattal E; Deverre JR
Biochimie; 2006 Nov; 88(11):1843-9. PubMed ID: 16860919
[TBL] [Abstract][Full Text] [Related]
16. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
[TBL] [Abstract][Full Text] [Related]
17. Chelation therapy with 3,4,3-Li(1,2-HOPO) after pulmonary exposure to plutonium in rats.
Grémy O; Devilliers K; Miccoli L
Chem Biol Interact; 2023 Jun; 378():110488. PubMed ID: 37054935
[TBL] [Abstract][Full Text] [Related]
18. Modelling DTPA therapy following Am contamination in rats.
Kastl M; Grémy O; Lamart S; Giussani A; Li WB; Hoeschen C
Radiat Environ Biophys; 2023 Nov; 62(4):483-495. PubMed ID: 37831188
[TBL] [Abstract][Full Text] [Related]
19. Improved Modeling of Plutonium-DTPA Decorporation.
Dumit S; Avtandilashvili M; Strom DJ; McComish SL; Tabatadze G; Tolmachev SY
Radiat Res; 2019 Feb; 191(2):201-210. PubMed ID: 30566387
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
Sérandour AL; Grémy O; Fréchou M; Renault D; Poncy JL; Fritsch P
Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
